| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/11/2003 | US20030229122 Use of methylphenidate compounds to enhance memory |
| 12/11/2003 | US20030229120 Zinc binding ligand; sustained release of insulin |
| 12/11/2003 | US20030229118 Method of use of (imidazol-5-yl)methyl-2-quinolinone derivatives to inhibit smooth muscle cell proliferation |
| 12/11/2003 | US20030229117 Administering cyclic nucleotide |
| 12/11/2003 | US20030229116 Enamine derivatives |
| 12/11/2003 | US20030229115 Organ rejection disease; autoimmune disease; immunosuppressants |
| 12/11/2003 | US20030229114 Central nervous system disorders; Alzheimer's disease, Parkinson's disease; Huntington's disease; strokes |
| 12/11/2003 | US20030229112 Synergistic mixture of temozolomide and irinotecan |
| 12/11/2003 | US20030229111 Naltrexone hydrochloride compositions |
| 12/11/2003 | US20030229110 Cell signal transduction |
| 12/11/2003 | US20030229109 Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same |
| 12/11/2003 | US20030229108 Angiogenesis inhibitors; antitumor agents, anticancer agents |
| 12/11/2003 | US20030229107 Magnetic resonance with stimulation |
| 12/11/2003 | US20030229105 Treatment of autoimmune disorders |
| 12/11/2003 | US20030229104 Substituted 3,4-dihydropyrido[1,2-a]pyrimidines |
| 12/11/2003 | US20030229102 Sulfonamide derivatives |
| 12/11/2003 | US20030229101 Tablets comprising ciprofloxacin hydrochloride |
| 12/11/2003 | US20030229100 Anticholesterol agents; antidiabetic agents; hypotensive agents |
| 12/11/2003 | US20030229097 Potentiation of fungicides |
| 12/11/2003 | US20030229096 Substituted imidazol-pyridazine derivatives |
| 12/11/2003 | US20030229095 Sexual disorders |
| 12/11/2003 | US20030229094 Acetamides and benzamides that are useful in treating sexual dysfunction |
| 12/11/2003 | US20030229093 Lipid diseases; metabolism diosrders; antiproliferative agents |
| 12/11/2003 | US20030229092 Antidiabetic agents; antiinflammatory agents; analgesics; antiallergens |
| 12/11/2003 | US20030229088 Novel methods and compositions for alleviating pain |
| 12/11/2003 | US20030229086 Central nervous system disorders; side effect reduction |
| 12/11/2003 | US20030229083 Compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them |
| 12/11/2003 | US20030229082 Viricides |
| 12/11/2003 | US20030229080 Cardiovascular disorders; sexual disorders |
| 12/11/2003 | US20030229079 1-(Aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof |
| 12/11/2003 | US20030229078 Prevent apoptosis; vision defects; central nervous system disorders; antiischemic agents; stroke therapy |
| 12/11/2003 | US20030229077 Nitrogen-containing heterocyclic compounds |
| 12/11/2003 | US20030229075 Induce immunology response; genetic engineering; gene expression; crystallization |
| 12/11/2003 | US20030229074 Metabolism; eating disorders; sexual disorders |
| 12/11/2003 | US20030229073 Tricyclic compounds and method of treating herpes virus |
| 12/11/2003 | US20030229072 Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binning agents |
| 12/11/2003 | US20030229070 Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonist and alpha-1-blocking action |
| 12/11/2003 | US20030229069 1-Sulfonyl-4-aminoalkoxy indole derivatives and uses thereof |
| 12/11/2003 | US20030229068 Controlling apoptosis, cell proliferation; strokes; anticancer agents; central nervous system disorders |
| 12/11/2003 | US20030229067 Sedative, vasodilation, antiarrhythmia agents, antiallergens, antiinflammatory agents |
| 12/11/2003 | US20030229065 Measuring drug resistance, calibration; reducing antibiotic resistance |
| 12/11/2003 | US20030229064 Method of treating cancer using dithiocarbamate derivatives |
| 12/11/2003 | US20030229063 Use of 4-hydroxytestosterone to lower estrogen levels in humans |
| 12/11/2003 | US20030229062 Treatments for age-related macular degeneration (AMD) |
| 12/11/2003 | US20030229061 Novel 2-alkoxyestradiol analogs with antiproliferative and antimitotic activity |
| 12/11/2003 | US20030229060 Steroidal quinols and their use for antioxidant therapy |
| 12/11/2003 | US20030229058 Aryl aniline beta2 adrenergic receptor agonists |
| 12/11/2003 | US20030229057 Continuous sulfatase inhibiting progestogen hormone replacement therapy |
| 12/11/2003 | US20030229055 Methods of simultaneously treating ocular rosacea and acne rosacea |
| 12/11/2003 | US20030229054 Novel amines as pharmaceutical agents |
| 12/11/2003 | US20030229053 Compounds and methods for the treatment or prevention of flavivirus infections |
| 12/11/2003 | US20030229052 Aqueous ifosfamide composition |
| 12/11/2003 | US20030229051 Anticancer agents; restenosis; atherosclerosis; skin disorders |
| 12/11/2003 | US20030229049 Injectable mixture of chondrosamine sulfate, glucosamine hydrochloride, dimethyl sulfoxide and dextrose with anesthetic |
| 12/11/2003 | US20030229048 Skin disorders; antiinflammatory agents |
| 12/11/2003 | US20030229047 Liquid formulation of decitabine and use of the same |
| 12/11/2003 | US20030229045 CFTR gene regulator |
| 12/11/2003 | US20030229044 Use of statins and other immunomodulatory agents in the treatment of autoimmune disease |
| 12/11/2003 | US20030229043 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes |
| 12/11/2003 | US20030229041 Administering steroid compound |
| 12/11/2003 | US20030229039 Gene therapy; mutant Dna |
| 12/11/2003 | US20030229035 Method of restoring ciliated cell motility |
| 12/11/2003 | US20030229032 Parasiticides, nematocides |
| 12/11/2003 | US20030229031 13-Methyl erythromycin derivatives |
| 12/11/2003 | US20030229030 Method of treating interleukin-6-mediated inflammatory diseases |
| 12/11/2003 | US20030229029 Cardiac glycosides for treating muscle pain and spasm |
| 12/11/2003 | US20030229027 In mixture of sugar and,or sugar alcohol |
| 12/11/2003 | US20030229025 Antidiabetic agents, eating disorders, dietetics |
| 12/11/2003 | US20030229024 Methods and compounds for inhibiting beta-amyloid peptide release and/or its synthesis |
| 12/11/2003 | US20030229023 Anticancer agents; skin disorders; antiinflamamtory agents; antiarthritic agents |
| 12/11/2003 | US20030229008 Regenerating organs; anticancer agents; autoimmune disease; stabilization cells |
| 12/11/2003 | US20030229007 Form of human renin and its use as a target in treatments for cardiac ischemia and arrhythmia |
| 12/11/2003 | US20030229004 Modulation of tumor cells using BER inhibitors in combination with a sensitizing agent and DSBR inhibitors |
| 12/11/2003 | US20030229003 Use of transcription factors for treating inflammation and other diseases |
| 12/11/2003 | US20030229002 Use of agents that modulate PDE11A activity |
| 12/11/2003 | US20030229001 Administering oxytocin antagonist |
| 12/11/2003 | US20030228675 Comprises nucleotide sequences coding phosphoinositide 3-kinase related kinases (PIKKS) for diagnosing and treating cell proliferative and apoptotic disorders |
| 12/11/2003 | US20030228662 Comprises nucleotide sequences coding tetrodoxin resistant transport protein for diagnosing, prevention and treatment of pain, muscular and cardiac disorders |
| 12/11/2003 | US20030228640 Using early prostate antigen as tool in diagnosis, prognosis and treatment of cancer |
| 12/11/2003 | US20030228606 Her-2 receptor tyrosine kinase molecules and uses thereof |
| 12/11/2003 | US20030228576 Nucleotide sequence coding for a cleaving enzyme; can use in conjuction with substrate to produce toxins which impair abnormal cell growth; antitumor agents |
| 12/11/2003 | US20030228573 Contacting test compound with Gag283 and determining its ability to bind to the apical cleft near the C-terminal domain; use in treatment of Acquired Immunodeficiency Syndrome (AIDS) |
| 12/11/2003 | US20030228568 Inducible phosphofructokinase and the warburg effect |
| 12/11/2003 | US20030228402 Mixture of terpene and,or liposome, surfactant and carrier; prevention gastrointestinal disorders |
| 12/11/2003 | US20030228394 Novel chromium (III) alpha amino acid complexes |
| 12/11/2003 | US20030228382 Foot Fixer Kit |
| 12/11/2003 | US20030228381 Bioavailability enhancing activity of Carum carvi extracts and fractions thereof |
| 12/11/2003 | US20030228380 Central nervous system diosrders; reduction of estrogen after menopause |
| 12/11/2003 | US20030228378 Water-soluble stable salts of petroselinic acid |
| 12/11/2003 | US20030228376 Novel topical microbicidal compositions |
| 12/11/2003 | US20030228375 Extract of deer antlers; adjust testosterone concentration; sexual disorders |
| 12/11/2003 | US20030228373 Composition including a triamine and a biocide and a method for inhibiting the growth of microorganisms with the same |
| 12/11/2003 | US20030228372 Animal extract in cyclodextrin matrix; antiaging agents, immunology response |
| 12/11/2003 | US20030228370 Orodispersible solid pharmaceutical form |
| 12/11/2003 | US20030228369 Process for conversion of high viscosity fluids and compositions thereof |
| 12/11/2003 | US20030228363 Stabilized pharmaceutical compositons containing benzimidazole compounds |
| 12/11/2003 | US20030228362 Controlled release lipoic acid |
| 12/11/2003 | US20030228361 Hypotensive agents; cardiovascular disorders |
| 12/11/2003 | US20030228360 Combination immediate release controlled release levodopa/carbidopa dosage forms |
| 12/11/2003 | US20030228359 Antiallergen mixture |